ALLOAllogene Therapeutics, Inc.Mar 12, 2026Q4 2025
Read transcript →Allogene Therapeutics, Inc. (ALLO)
NASDAQ·Healthcare·Biotechnology
$2.20
-2.05%
Mkt Cap $563.34M
ALLOAllogene Therapeutics, Inc.Mar 12, 2026ALLOAllogene Therapeutics, Inc.Nov 7, 2025Q3 2025
Read transcript →ALLOAllogene Therapeutics, Inc.Aug 13, 2025Q2 2025
Read transcript →ALLOAllogene Therapeutics, Inc.May 13, 2025Q1 2025
Read transcript →ALLOAllogene Therapeutics, Inc.Mar 13, 2025Q4 2024
Read transcript →ALLOAllogene Therapeutics, Inc.Nov 7, 2024Q3 2024
Read transcript →ALLOAllogene Therapeutics, Inc.May 13, 2024Q1 2024
Read transcript →ALLOAllogene Therapeutics, Inc.Mar 14, 2024Q4 2023
Read transcript →ALLOAllogene Therapeutics, Inc.Nov 2, 2023Q3 2023
Read transcript →ALLOAllogene Therapeutics, Inc.Aug 2, 2023Q2 2023
Read transcript →ALLOAllogene Therapeutics, Inc.May 3, 2023Q1 2023
Read transcript →ALLOAllogene Therapeutics, Inc.Feb 28, 2023Q4 2022
Read transcript →ALLOAllogene Therapeutics, Inc.Nov 2, 2022Q3 2022
Read transcript →ALLOAllogene Therapeutics, Inc.Aug 9, 2022Q2 2022
Read transcript →ALLOAllogene Therapeutics, Inc.May 4, 2022Q1 2022
Read transcript →ALLOAllogene Therapeutics, Inc.Feb 23, 2022Q4 2021
Read transcript →ALLOAllogene Therapeutics, Inc.Nov 4, 2021Q3 2021
Read transcript →ALLOAllogene Therapeutics, Inc.Aug 4, 2021Q2 2021
Read transcript →ALLOAllogene Therapeutics, Inc.May 5, 2021Q1 2021
Read transcript →ALLOAllogene Therapeutics, Inc.Feb 28, 2021Q4 2020
Read transcript →ALLOAllogene Therapeutics, Inc.Nov 4, 2020Q3 2020
Read transcript →ALLOAllogene Therapeutics, Inc.Aug 6, 2020Q2 2020
Read transcript →ALLOAllogene Therapeutics, Inc.May 9, 2020Q1 2020
Read transcript →ALLOAllogene Therapeutics, Inc.Feb 27, 2020Q4 2019
Read transcript →ALLOAllogene Therapeutics, Inc.Nov 5, 2019Q3 2019
Read transcript →ALLOAllogene Therapeutics, Inc.Aug 7, 2019Q2 2019
Read transcript →ALLOAllogene Therapeutics, Inc.May 11, 2019Q1 2019
Read transcript →ALLOAllogene Therapeutics, Inc.Mar 9, 2019Q4 2018
Read transcript →